Search
Element Search
Structure Search
Thermo Scientific Chemicals
2-Bromobenzimidazole, 99%
CAS: 54624-57-6 | C7H5BrN2 | 197.035 g/mol
Have Questions?
Change view
Catalog number H26183.03
also known as H26183-03
Price (USD)
75.65
Online Exclusive
83.70Save 8.05 (10%)
Each
Quantity:
1 g
Price (USD)
75.65
Online Exclusive
83.70Save 8.05 (10%)
Each
Chemical Identifiers
CAS54624-57-6
IUPAC Name2-bromo-1H-1,3-benzodiazole
Molecular FormulaC7H5BrN2
InChI KeyPHPYXVIHDRDPDI-UHFFFAOYSA-N
SMILESBrC1=NC2=CC=CC=C2N1
View more
Specifications
Specification Sheet
Specification SheetAppearance (Color)White to cream
FormCrystals or powder or crystalline powder
Assay (GC)≥98.5%
Proton NMRConforms to structure
Reactant in the synthesis of substituted benzimidazoles. 2-Bromobenzimidazole is the starting compound in the synthesis of polyhalogenobenzimidazoles.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Reactant in the synthesis of substituted benzimidazoles. 2-Bromobenzimidazole is the starting compound in the synthesis of polyhalogenobenzimidazoles.
Solubility
Insoluble in water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.
Reactant in the synthesis of substituted benzimidazoles. 2-Bromobenzimidazole is the starting compound in the synthesis of polyhalogenobenzimidazoles.
Solubility
Insoluble in water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.
RUO – Research Use Only
General References:
- Mariola Andrzejewska,; Mario A Pagano,; Flavio Meggio,; Anna Maria Brunati,; Zygmunt Kazimierczuk. Polyhalogenobenzimidazoles: synthesis and Their inhibitory activity against casein kinases. Bioorganic & Medicinal Chemistry. 2003, 11 (18), 3997-4002.
- Zhongsheng Zhang,; Kayode K. Ojo,; Steven M. Johnson,; Eric T. Larson,; Penqing He,; Jennifer A. Geiger. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. Bioorganic & Medicinal Chemistry Letters. 2012, 22(16), 5264-5267.